BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Staging
14 results:

  • 1. The Yin and Yang of erbb4: Tumor Suppressor and Oncoprotein.
    Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
    Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Update of the Management of Cutaneous Squamous-cell Carcinoma.
    Maubec E
    Acta Derm Venereol; 2020 Jun; 100(11):adv00143. PubMed ID: 32346744
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cutaneous Squamous Cell Carcinoma: Updates in staging and Management.
    Bander TS; Nehal KS; Lee EH
    Dermatol Clin; 2019 Jul; 37(3):241-251. PubMed ID: 31084718
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
    Antoun S; Morel H; Souquet PJ; Surmont V; Planchard D; Bonnetain F; Foucher P; Egenod T; Krakowski I; Gaudin H; Debieuvre D
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):782-793. PubMed ID: 30932365
    [TBL] [Abstract] [Full Text] [Related]  

  • 5.
    Jain A; Kameswaran M; Pandey U; Prabhash K; Sarma HD; Dash A
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4552-4557. PubMed ID: 28893469
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Management of High-Risk Squamous Cell Carcinoma of the skin.
    Fu T; Aasi SZ; Hollmig ST
    Curr Treat Options Oncol; 2016 Jul; 17(7):34. PubMed ID: 27262708
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
    Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
    Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. egfr activated cell mobility - A link to melanoma ulceration.
    Katunarić M; Zamolo G; Jonjić N
    Med Hypotheses; 2015 Oct; 85(4):498-9. PubMed ID: 26189002
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pharmacologic treatment options for advanced epithelial skin cancer.
    Soura E; Chasapi V; Stratigos AJ
    Expert Opin Pharmacother; 2015; 16(10):1479-93. PubMed ID: 26027692
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. microRNA portraits in human vulvar carcinoma.
    de Melo Maia B; Lavorato-Rocha AM; Rodrigues LS; Coutinho-Camillo CM; Baiocchi G; Stiepcich MM; Puga R; de A Lima L; Soares FA; Rocha RM
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1231-41. PubMed ID: 24048714
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma.
    Degen M; Natarajan E; Barron P; Widlund HR; Rheinwald JG
    Am J Pathol; 2012 Jun; 180(6):2462-78. PubMed ID: 22546478
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience.
    Ren G; Du L; Ma L; Feng LC; Zhou GX; Qu BL; Xu SP; Xie CB; Ou GM; Li F; Zhang XX; Yang J
    Technol Cancer Res Treat; 2011 Jun; 10(3):259-66. PubMed ID: 21517132
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
    Folprecht G; Gruenberger T; Bechstein WO; Raab HR; Lordick F; Hartmann JT; Lang H; Frilling A; Stoehlmacher J; Weitz J; Konopke R; Stroszczynski C; Liersch T; Ockert D; Herrmann T; Goekkurt E; Parisi F; Köhne CH
    Lancet Oncol; 2010 Jan; 11(1):38-47. PubMed ID: 19942479
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mechanisms of cutaneous toxicities to egfr inhibitors.
    Lacouture ME
    Nat Rev Cancer; 2006 Oct; 6(10):803-12. PubMed ID: 16990857
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.